Andrew Schneider, DPM
Podiatrist · Houston, TXNPI 1982600177
Payments from drug & device makers
What this record shows
This record is dominated by other: $146,200 of the $150,172 with a category attached, or 97.4%. Convatec Inc. accounts for 97.4% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2024 at $146,400 and has fallen 98.1% since, to $2,776 in 2025. Among podiatrist clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 98 payments — averaging $1532.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Convatec Inc.$146K
- Stryker$2K
- Treace Medical Concepts, Inc.$809
- Paratek Pharmaceuticals, Inc.$175
- GRT US Holding, Inc.$100
- Amgen$71
- plus $535 from 17 others
Across 1 payment — averaging $28,433 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$28K
What the payments were for
- Travel & lodging$1,4461%
- Food & beverage$2,5262%
- Other$146,20097%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Convatec Inc. | 12 | $146,200 |
| Stryker | 28 | $2,282 |
| Treace Medical Concepts, Inc. | 16 | $809 |
| Paratek Pharmaceuticals, Inc. | 8 | $175 |
| GRT US Holding, Inc. | 2 | $100 |
| Amgen(2 entities) | 4 | $71 |
| Smith+Nephew | 4 | $69 |
| Bioventus LLC | 3 | $67 |
| Nevro Corp. | 3 | $66 |
| Heron Therapeutics, Inc. | 3 | $59 |
| Medtronic | 2 | $43 |
| Innovation Technologies Inc | 1 | $26 |
| Arthrosurface Incorporated | 1 | $26 |
| Mimedx Group, Inc. | 1 | $22 |
| Dynasplint Systems Inc. | 2 | $22 |
| Abbott | 1 | $22 |
| Zimmer Biomet | 1 | $20 |
| Amniox Medical, Inc. | 1 | $19 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $18 |
| Apyx Medical Corporation | 1 | $16 |
| Argentum Medical | 1 | $14 |
| Triad Life Sciences Inc. | 1 | $13 |
| Anika Therapeutics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$146,200
- PROstep$1,119
- Lapiplasty$275
- BIO4$144
- AUGMENT INJECTABLE$138
- LAPIPLASTY SYSTEM 1$107
How this compares
$150,172 in reported general payments places this provider in the 95th percentile of 470 podiatrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 19 | $522 |
| Methylprednisolone | 47 | $293 |
| Meloxicam | 41 | $155 |
| Mupirocin | 22 | $124 |
| Allopurinol | 13 | $85 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $64 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Houston
- Gary LepowHouston$1M
- Randall BeckmanHouston$103K
- Jason ArmstrongHouston$91K
- Jerry MilesHouston$58K
- Tina OliverHouston$42K
- Lawrence MactavishHouston$41K
- Roberto de Los SantosHouston$33K
- Randal LepowHouston$33K
- Ava WashkoHouston$19K
- Jeffrey RossHouston$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.